ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,114.63
-0.01%
US Tech 100
21,524.40
0.41%
다우존스 지수
44,546.08
-0.37%
Bitcoin
97,534.22
0.01%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Zymeworks Inc (ZYME)

  7. Zymeworks Inc (ZYME) 뉴스

ZYME

Zymeworks (ZYME)

Zymeworks Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ZYME
일자시간출처헤드라인심볼기업
2025/02/1320:00GlobeNewswire Inc.Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025NASDAQ:ZYMEZymeworks Inc
2025/01/3020:00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
2025/01/1409:18Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:ZYMEZymeworks Inc
2025/01/1108:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
2025/01/0906:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
2025/01/0906:05GlobeNewswire Inc.Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026NASDAQ:ZYMEZymeworks Inc
2025/01/0710:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
2025/01/0709:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ZYMEZymeworks Inc
2024/12/1308:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
2024/12/1307:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
2024/12/1307:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZYMEZymeworks Inc
2024/12/1222:30GlobeNewswire Inc.Zymeworks Hosts R&D Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion into Autoimmune and Inflammatory DiseasesNASDAQ:ZYMEZymeworks Inc
2024/12/1206:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
2024/11/2206:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
2024/11/2120:05GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
2024/11/2120:00GlobeNewswire Inc.FDA Grants U.S. Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)NASDAQ:ZYMEZymeworks Inc
2024/11/0520:00GlobeNewswire Inc.Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid TumorsNASDAQ:ZYMEZymeworks Inc
2024/11/0105:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZYMEZymeworks Inc
2024/11/0105:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
2024/11/0105:05GlobeNewswire Inc.Zymeworks Provides Corporate Update and Reports Third Quarter 2024 Financial ResultsNASDAQ:ZYMEZymeworks Inc
2024/10/3005:11Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ZYMEZymeworks Inc
2024/10/3005:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZYMEZymeworks Inc
2024/10/3005:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ZYMEZymeworks Inc
2024/10/2919:00GlobeNewswire Inc.Zymeworks Announces Participation in Upcoming Investor ConferencesNASDAQ:ZYMEZymeworks Inc
2024/10/2519:00GlobeNewswire Inc.Zymeworks Presents New Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR ConferenceNASDAQ:ZYMEZymeworks Inc
2024/10/2119:00GlobeNewswire Inc.Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing CancersNASDAQ:ZYMEZymeworks Inc
2024/10/1905:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZYMEZymeworks Inc
2024/10/1019:30GlobeNewswire Inc.Zymeworks to Report Third Quarter 2024 Financial Results and Host Conference Call on October 31, 2024NASDAQ:ZYMEZymeworks Inc
2024/09/1819:00GlobeNewswire Inc.Zymeworks to Present Preclinical Data on Antibody-Drug Conjugate Programs at EORTC-NCI-AACR ConferenceNASDAQ:ZYMEZymeworks Inc
2024/09/0405:30GlobeNewswire Inc.Zymeworks Reports Inducement Grant Under Nasdaq Stock Market Rule 5635(c)NASDAQ:ZYMEZymeworks Inc
 검색 관련기사 보기:NASDAQ:ZYME

최근 히스토리

PM
XAUUSD
Gold vs US Dollar
NYSE
VZ
Verizon Communications
USI
USTECH100
US Tech 100
AMEX
XLE
Energy Select Sector SPDR
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
NYSE
CVX
Chevron
CCOM
US100
US Tech 100
NASDAQ
QQQ
Invesco QQQ Trust Series 1
COIN
DOGEUSD
Dogecoin
USOTC
BASFY
BASF (QX)
CCOM
US500
US 500
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지